Heidelberg Materials (ETR:HEI) used its 137th annual general meeting to highlight record 2025 results, a higher proposed dividend, continued share buybacks and progress on decarbonization and digitalization initiatives.
Bernd Scheifele, chairman of the Supervisory Board, opened the virtual AGM and
Avon Protection (LON:AVON) reported a strong first half, with executives saying revenue, profit and returns improved materially as the group’s multi-year transformation program nears completion and its defense and first responder markets remain supportive.
Chief Executive Jos Sclater said the compa
Hapag-Lloyd Aktiengesellschaft (ETR:HLAG) reported a weaker first quarter of 2026, with management describing the start to the year as “unsatisfactory” as severe weather, weak Atlantic trade and higher costs tied to Middle East tensions weighed on results.
Chief Executive Officer Rolf Habben Jansen
JOST Werke (ETR:JST) reported a record first quarter for 2026, with management citing strong organic growth, early benefits from the Hyva integration and improving profitability despite mixed global market conditions.
Chief Executive Officer Joachim Dürr said the company had a “very strong start” t
The U.S. stock market is expensive by historical standards, and the Federal Reserve warns that elevated energy prices could lead to interest rate hikes.
Enviri (NYSE:NVRI) reported first-quarter 2026 revenue that was flat from a year earlier, while executives said the company remains on track to complete the sale of Clean Earth and the spin-off of New Enviri around June 1.
Chairman and Chief Executive Officer Nick Grasberger said shareholders appro
Envista (NYSE:NVST) reported a strong start to 2026, with management citing broad-based growth across its major dental businesses, margin expansion and continued investment in new products and commercial capabilities.
On the company’s first-quarter earnings call, President and CEO Paul Keel said En
Caris Life Sciences (NASDAQ:CAI) executives said the company is expanding its commercial reach, product pipeline and biopharma partnerships as it looks to build on recent revenue growth following its IPO last June.
Speaking at an investor conference, a Caris executive identified by Chief Scientific
Grenke (ETR:GLJ) said its first-quarter 2026 results showed progress on profitability and cost discipline despite what Chief Financial Officer Dr. Martin Paal described as an “unchanged, challenging macroeconomic environment” marked by geopolitical tensions, elevated insolvencies in many European co
Babcock International Group (LON:BAB) executives said the defense contractor delivered a strong underlying performance in fiscal 2026, but the update was overshadowed by a new GBP 140 million charge tied to its Type 31 frigate program.
Speaking on a post-close trading update call, Group CEO David L
Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity franchise and a series of pipeline and regulatory milestones, even as adjusted sales declined because of lower realized prices.
Chi
